Magstim PlatoScience tDCS Webinar video 24

Magstim New Product Launch Webinar Video
tDCS Product Launch Education
Transcranial direct current stimulation
Learn about transcranial direct current stimulation.
tDCS is an evidence-based, non-invasive, neuromodulation technique for supporting the treatment of psychiatric and psychological conditions. Magstim has partnered with PlatoScience, a leader in tDCS, to offer researchers and clinicians this neuromodulation technology to support patient treatments and neuroscience research studies.
Join Balder Onarheim, PhD, CEO PlatoScience, as he shares insights and applications for this technology.
Latest guidance issue by the International Federation of Clinical Neurophysiology (IFCN) on the use of tDCS in the treatment of neurophysiological diseases found Level B evidence (probable efficacy) for:
(i) anodal tDCS of the left primary motor cortex (M1) (with right orbitofrontal cathode) in fibromyalgia;
(ii) anodal tDCS of the left dorsolateral prefrontal cortex (DLPFC) (with right orbitofrontal cathode) in major depressive episode without drug resistance;
(iii) anodal tDCS of the right DLPFC (with left DLPFC cathode) in addiction/craving.
Level C recommendation (possible efficacy) is proposed for:
(i) anodal tDCS of the left M1 (or contralateral to pain side, with right orbitofrontal cathode) in chronic lower limb neuropathic pain secondary to spinal cord lesion.*
Note: PlatoScience products are not standalone treatments but supportive tools for professional healthcare providers.
More at www.Magstim.com